Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WMB vs GSK✓SelectedUSD · GSKWMB vs GSK performance historyLatest closeAs of-2.14%11/16
Stock and ETF performance explorer

WMB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+198.6%
GSK return
+47.4%
Excess return
+151.2%
Maximum drawdown
-23.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.1%-0.1%-2.1%-2.1%
7D+1.7%-1.3%+3.1%+1.8%
30D-5.1%+2.7%-7.9%-5.3%
3M-9.4%+2.7%-12.2%-9.6%
6M-11.7%+3.3%-15.1%-12.0%
YTD+15.0%+6.5%+8.5%+13.8%
1Y+14.2%+10.7%+3.6%+12.6%
3Y+117.7%+64.4%+53.3%+98.5%
All+198.6%+47.4%+151.2%+170.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling